Strikingly, SIRT2/3−/− macrophages favor fatty acid oxidation over glycolysis, and SIRT2/3−/− mice are robustly protected from endotoxemia [148]. The gene discussed is SIRT2; the disease is serum lipopolysaccharide activity.